Quantification of γδ T cells and HLA-DR+ NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment.

by Mindaugas Paužuolis, Torsten Eich, Joachim Burman
Published 2017-01-01

Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

by Joakim Bergman, Anders Svenningsson, Per Liv, Tommy Bergenheim, Joachim Burman
Published 2020-07-01

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis

by Stephanie Herman, Torbjörn Åkerfeldt, Ola Spjuth, Joachim Burman, Kim Kultima
Published 2019-01-01

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.

by Valter Niemelä, Joachim Burman, Kaj Blennow, Henrik Zetterberg, Anders Larsson, Jimmy Sundblom
Published 2018-01-01

Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid

by Kristian Peters, Stephanie Herman, Payam Emami Khoonsari, Joachim Burman, Steffen Neumann, Kim Kultima
Published 2021-09-01

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing

by Henrik Carlsson, Niclas Rollborn, Stephanie Herman, Eva Freyhult, Anders Svenningsson, Joachim Burman, Kim Kultima
Published 2021-02-01

Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for...

by Fiona Roberts, Helen Hobbs, Helen Jessop, Cristina Bozzolini, Joachim Burman, Raffaella Greco, Azza Ismail, Majid Kazmi, Kirill Kirgizov, Gianluigi Mancardi, Susan Mawson, Paolo A. Muraro, Mathieu Puyade, Mathieu Puyade, Riccardo Saccardi, Barbara Withers, Bregje Verhoeven, Basil Sharrack, Basil Sharrack, John A. Snowden
Published 2020-12-01